Douglass Brian Robb bought RGEN
December 31, 2025 · Form 4 insider transaction
Douglass Brian Robb bought 2,288 shares of Repligen Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 12 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,288
Price
$0.00
Total value
N/A
InsiderDouglass Brian Robb
RoleOfficer
CompanyRepligen Corporation (RGEN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 12, 2026
Shares owned after8,540
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock.